BioPharma Credit PLC's Fiscal Year is From January To December.
The item "Price-To-Sales-Ratio" stands at 6.99 as of 06/30/2025.
As of the end of BioPharma Credit PLC's second quarter, the item "Price To Sales Ratio" stands at 6.99. This represents a decrease of -0.95 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 73.12 percent compared to the value the year prior.
The 1 year change in percent is 73.12.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Berkshire Hathaway Inc - Price To Sales Ratio | 1,088,030,244,864.00 |
![]() | Blackstone Group Inc - Price To Sales Ratio | 186,696,990,720.00 |
![]() | BlackRock Inc - Price To Sales Ratio | 166,346,604,544.00 |
![]() | KKR & Co LP - Price To Sales Ratio | 119,832,821,760.00 |
![]() | Mitsubishi Corp. - Price To Sales Ratio | 89,722,540,958.42 |